By Drug Class / Mechanism

Other Adjuvants (Neostigmine, Ketamine, Opioids) Market Analysis

Cross-industry research covering Other Adjuvants (Neostigmine, Ketamine, Opioids) across 1 market reportspanning Pharmaceuticals / Medical Devices — Regional Anesthesia.

1 Reports

1 Industries

Reports Covering Other Adjuvants (Neostigmine, Ketamine, Opioids)

Nerve Blocks Market to Reach USD 9.4 Billion by 2033 at 6.4% CAGR

Pharmaceuticals / Medical Devices — Regional Anesthesia·Market: USD 5.7 Billion (2025)·CAGR: 6.4%

Neostigmine as a cholinergic adjuvant in TAP block for cesarean section (nct:NCT05785377) exemplifies the investigational use of agents outside the canonical alpha-2/steroid adjuvant toolkit. Perineural dexamethasone and magnesium are also widely used off-label. This heterogeneous class has limited near-term commercialization upside given generic pricing, but protocol standardization could increase per-case revenue through documented multi-agent combinations that support higher procedure billing complexity.

13%

Market Share

5.9%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments